VA Awards $1.2M for Toxicology Reagents & Equipment to Microgenics Corporation
Contract Overview
Contract Amount: $119,990 ($120.0K)
Contractor: Microgenics Corporation
Awarding Agency: Department of Veterans Affairs
Start Date: 2024-10-01
End Date: 2026-03-30
Contract Duration: 545 days
Daily Burn Rate: $220/day
Competition Type: COMPETED UNDER SAP
Number of Offers Received: 1
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: TOXICOLOGY REAGENTS AND EQUIPMENT
Place of Performance
Location: FREMONT, ALAMEDA County, CALIFORNIA, 94538
Plain-Language Summary
Department of Veterans Affairs obligated $119,989.99 to MICROGENICS CORPORATION for work described as: TOXICOLOGY REAGENTS AND EQUIPMENT Key points: 1. Contract awarded to Microgenics Corporation for toxicology reagents and equipment. 2. The Department of Veterans Affairs is the procuring agency. 3. The contract has a duration of 545 days. 4. This award falls under the In-Vitro Diagnostic Substance Manufacturing sector.
Value Assessment
Rating: fair
The award amount of $1.2M for toxicology reagents and equipment appears reasonable given the contract duration and the nature of specialized diagnostic supplies. Benchmarking against similar contracts for reagents and equipment is necessary for a definitive assessment.
Cost Per Unit: N/A
Competition Analysis
Competition Level: limited
The contract was competed under SAP (Simplified Acquisition Procedures), suggesting a limited competition environment. While SAP aims for efficiency, it may not always yield the lowest possible price compared to full and open competition.
Taxpayer Impact: The use of SAP for this award may result in a slightly higher cost to taxpayers than if it were fully competed, though the value is likely within an acceptable range for specialized supplies.
Public Impact
Ensures VA medical facilities have necessary toxicology testing capabilities. Supports diagnostic services for veterans' health. Potential impact on the availability of specialized reagents for medical labs.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Limited competition under SAP
- Potential for price increases due to limited competition
Positive Signals
- Supports critical healthcare services for veterans
- Utilizes a fixed-price contract type
Sector Analysis
The contract falls within the In-Vitro Diagnostic Substance Manufacturing sector, which is crucial for healthcare. Spending in this sector is driven by demand for accurate and timely medical testing, with benchmarks varying based on the specific reagents and equipment required.
Small Business Impact
Information regarding small business participation is not available for this specific award. Further analysis would be needed to determine if small businesses were involved in the subcontracting or prime contracting.
Oversight & Accountability
The Department of Veterans Affairs is responsible for oversight of this contract. The use of a BPA Call indicates a pre-existing agreement, and oversight would focus on adherence to terms and delivery schedules.
Related Government Programs
- In-Vitro Diagnostic Substance Manufacturing
- Department of Veterans Affairs Contracting
- Department of Veterans Affairs Programs
Risk Flags
- Potential for higher costs due to limited competition.
- Lack of detailed cost breakdown for specific items.
- Need for ongoing quality assurance to ensure effectiveness.
- Limited visibility into small business participation.
Tags
in-vitro-diagnostic-substance-manufactur, department-of-veterans-affairs, ca, bpa-call, 100k-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Veterans Affairs awarded $119,989.99 to MICROGENICS CORPORATION. TOXICOLOGY REAGENTS AND EQUIPMENT
Who is the contractor on this award?
The obligated recipient is MICROGENICS CORPORATION.
Which agency awarded this contract?
Awarding agency: Department of Veterans Affairs (Department of Veterans Affairs).
What is the total obligated amount?
The obligated amount is $119,989.99.
What is the period of performance?
Start: 2024-10-01. End: 2026-03-30.
What is the specific breakdown of reagents and equipment included in this award, and how does it align with VA's current needs?
The provided data does not detail the specific breakdown of toxicology reagents and equipment. A comprehensive needs assessment by the VA would be required to ensure this award directly addresses current requirements for diagnostic testing, patient care, and research objectives within their facilities.
Were alternative suppliers or methods considered during the SAP competition to ensure the best value for taxpayers?
While competed under SAP, the extent of alternative suppliers considered is not detailed. SAP allows for some level of competition, but it's less rigorous than full and open. The VA should have documented efforts to solicit quotes from multiple sources within the SAP framework to ensure competitive pricing.
How will the effectiveness of these toxicology reagents and equipment be measured to ensure quality patient outcomes?
Effectiveness will likely be measured through performance metrics tied to the quality and reliability of the reagents and equipment, such as accuracy rates, turnaround times for tests, and user feedback from laboratory staff. The VA's quality assurance processes will be critical in monitoring these aspects.
Industry Classification
NAICS: Manufacturing › Pharmaceutical and Medicine Manufacturing › In-Vitro Diagnostic Substance Manufacturing
Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
Competition & Pricing
Extent Competed: COMPETED UNDER SAP
Solicitation Procedures: SIMPLIFIED ACQUISITION
Offers Received: 1
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Parent Company: Thermo Fisher Scientific Inc.
Address: 46500 KATO RD, FREMONT, CA, 94538
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Manufacturer of Goods, Not Designated a Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $119,990
Exercised Options: $119,990
Current Obligation: $119,990
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES
Parent Contract
Parent Award PIID: 36C24120A0082
IDV Type: BPA
Timeline
Start Date: 2024-10-01
Current End Date: 2026-03-30
Potential End Date: 2026-03-30 00:00:00
Last Modified: 2026-04-06
Other Department of Veterans Affairs Contracts
- CCN Region 3 Express Report — $5.2B (Optum Public Sector Solutions, Inc.)
- Express Report for FY22 Region 2 — $5.1B (Optum Public Sector Solutions, Inc.)
- Fiscal Year 2022 Express Report for Region 1 — $4.2B (Optum Public Sector Solutions, Inc.)
- Express Report for the Patient Centered Community Care (PC3) Contract — $3.3B (Triwest Healthcare Alliance Corp)
- CCN Region Three FY21 Express Report — $3.1B (Optum Public Sector Solutions, Inc.)